NCT05773677

Brief Summary

The aim of this study is to evaluate how variations in maternal nutrition may affect twin pregnancy and in particular:

  • incidence of maternal obstetric complications:
  • gestational diabetes
  • gestational hypertension or preeclampsia
  • intrahepatic cholestasis (ICP)
  • fetal growth, development and birth weight of the babies

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 10, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 24, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 17, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
Last Updated

March 20, 2023

Status Verified

March 1, 2023

Enrollment Period

12 months

First QC Date

February 24, 2023

Last Update Submit

March 16, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • incidence of maternal obstetric complications:

    * gestational diabetes * gestational hypertension or preeclampsia -intrahepatic cholestasis (ICP)

    From enrollment in the study to delivery

Secondary Outcomes (3)

  • fetal growth and birth weight of the babies

    From enrollment in the study to delivery

  • maternal weight gain

    From enrollment in the study to delivery

  • differences in early or late enrollment of patients

    From enrollment in the study to delivery

Study Arms (2)

Case Group: with diet

EXPERIMENTAL

Prescription of specific diet in pregnancy

Dietary Supplement: Specific Diet

Control Group: no diet

NO INTERVENTION

Retrospective group with no diet

Interventions

Specific DietDIETARY_SUPPLEMENT

A specific diet will be developed for each patient, which will also take into account any food allergies or intolerances. Each diet will be then eventually modified and revised throughout the pregnancy, according to the evolution of the same.

Case Group: with diet

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • dichorionic-diamniotic twin pregnancies
  • monochorionic-diamniotic twin pregrancies
  • monochorionic- monoamniotic twin pregnancies
  • spontaneous onset or by homologous PMA techniques
  • Age between 18 and 40 years
  • Gestational age between 8 weeks+0 days and 25 weeks+6 days

You may not qualify if:

  • Pregestational diabetes mellitus (type I and II)
  • Chronic hypertension
  • Previous bariatric surgery
  • Chronic gastrointestinal disease (Celiac disease, Crohn's disease, Ulcerative Rectocolitis)
  • Age less than 18 years or more than 40 years
  • Gestational age less than 8 weeks or more than 26 weeks
  • Fetal structural and/or genetic abnormalities
  • Heterologous PMA
  • Maternal eating disorders
  • Drug and/or alcohol use
  • Multiple pregnancies with more than two babies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

FPGemelliIRCCS

Roma, 00168, Italy

RECRUITING

MeSH Terms

Conditions

Diabetes, GestationalHypertension, Pregnancy-InducedIntrahepatic Cholestasis of PregnancyFeeding Behavior

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHypertensionVascular DiseasesCardiovascular DiseasesBehavior, AnimalBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Case group: prospective Control group: retrospective
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 24, 2023

First Posted

March 17, 2023

Study Start

October 10, 2022

Primary Completion

October 1, 2023

Study Completion

April 1, 2024

Last Updated

March 20, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations